$1.09 Billion is the total value of Centerbridge Partners's 124 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOCO | GOHEALTH INC | $456,056,000 | -4.1% | 40,682,961 | 0.0% | 41.71% | -5.7% | |
| VTIQ | VECTOIQ ACQUISITION CORP II | $19,500,000 | +0.8% | 1,950,000 | 0.0% | 1.78% | -0.8% | |
| EIX | EDISON INTL | $8,295,000 | -1.3% | 143,471 | 0.0% | 0.76% | -2.9% | |
| PRPC | CC NEUBERGER PRINCIPAL HOLDN | $3,912,000 | +0.8% | 400,000 | 0.0% | 0.36% | -0.8% | |
| CFIV | CF ACQUISITION CORP IV | $1,580,000 | -0.9% | 163,000 | 0.0% | 0.14% | -2.0% | |
| AGCB | ALTIMETER GROWTH CORP 2 | $1,537,000 | -1.3% | 150,000 | 0.0% | 0.14% | -2.8% | |
| NXU | NOVUS CAPITAL CORPORATION II | $1,462,000 | +0.5% | 150,000 | 0.0% | 0.13% | -0.7% | |
| SHAC | SCP & CO HEALTHCARE ACQUSTN | $968,000 | +0.3% | 100,000 | 0.0% | 0.09% | -1.1% | |
| BIOT | BIOTECH ACQUISITION COMPANY | $967,000 | -0.5% | 100,000 | 0.0% | 0.09% | -2.2% | |
| CPTK | CROWN PROPTECH ACQUISITIONS | $967,000 | +7.2% | 100,000 | 0.0% | 0.09% | +4.8% | |
| EQHA | EQ HEALTH ACQUISITION CORP | $483,000 | -0.2% | 50,000 | 0.0% | 0.04% | -2.2% | |
| PAQC | PROVIDENT ACQUISITION CORPcl a | $366,000 | -0.5% | 37,731 | 0.0% | 0.03% | -2.9% | |
| DUNEW | DUNE ACQUISITION CORP*w exp 10/29/202 | $120,000 | +29.0% | 150,001 | 0.0% | 0.01% | +22.2% | |
| CFIVW | CF ACQUISITION CORP IV*w exp 12/31/202 | $109,000 | +23.9% | 100,000 | 0.0% | 0.01% | +25.0% | |
| PRPCWS | CC NEUBERGER PRINCIPAL HOLDN*w exp 99/99/999 | $102,000 | +10.9% | 80,000 | 0.0% | 0.01% | 0.0% | |
| VIIAW | 7GC & CO HOLDINGS INC*w exp 12/23/202 | $84,000 | +20.0% | 92,501 | 0.0% | 0.01% | +14.3% | |
| NXUWS | NOVUS CAPITAL CORPORATION II*w exp 02/02/202 | $59,000 | +1.7% | 50,000 | 0.0% | 0.01% | 0.0% | |
| PAQCW | PROVIDENT ACQUISITION CORP*w exp 01/08/202 | $59,000 | -1.7% | 75,001 | 0.0% | 0.01% | -16.7% | |
| SHACW | SCP & CO HEALTHCARE ACQUSTN*w exp 01/27/202 | $42,000 | +40.0% | 50,000 | 0.0% | 0.00% | +33.3% | |
| BIOTW | BIOTECH ACQUISITION COMPANY*w exp 11/30/202 | $43,000 | +43.3% | 50,000 | 0.0% | 0.00% | +33.3% | |
| CFFVW | CF ACQUISITION CORP V*w exp 01/25/202 | $41,000 | +46.4% | 40,000 | 0.0% | 0.00% | +33.3% | |
| FCAXWS | FORTRESS CAPITAL ACQUISITION*w exp 99/99/999 | $32,000 | +6.7% | 30,000 | 0.0% | 0.00% | 0.0% | |
| CPTKWS | CROWN PROPTECH ACQUISITIONS*w exp 99/99/999 | $28,000 | +12.0% | 33,333 | 0.0% | 0.00% | +50.0% | |
| HCCCW | HEALTHCARE CAPITAL CORP*w exp 12/31/202 | $36,000 | +16.1% | 50,000 | 0.0% | 0.00% | 0.0% | |
| EQHAWS | EQ HEALTH ACQUISITION CORP*w exp 02/20/202 | $18,000 | +50.0% | 25,001 | 0.0% | 0.00% | +100.0% | |
| AACWS | ARES ACQUISITION CORPORATION"w exp 99/99/999 | $25,000 | +38.9% | 20,000 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Centerbridge Credit Advisors, L.L.C. #1
- Centerbridge Partners Holdings, LLC #2
- Aronson Jeffrey #3
- Gallogly Mark T #4
- Centerbridge Special Credit Advisors, L.L.C. #5
- Centerbridge Advisors, LLC #6
- Centerbridge Special Credit Advisors II, L.L.C #7
- Centerbridge Special Credit Advisors III, L.L.C. #8
- Centerbridge Advisors II, LLC #9
- Centerbridge Advisors III, LLC #10
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
About Centerbridge Partners
Centerbridge Partners is a private investment management firm that was founded in 2005 by Mark Gallogly and Jeffrey Aronson. The firm is headquartered in New York City and has additional offices in London and Hong Kong. Centerbridge Partners manages over $25 billion in assets across a range of investment strategies, including private equity, distressed debt, and real estate.
The firm has a strong leadership team, with Mark Gallogly serving as the CEO and Jeffrey Aronson as the Chairman and Chief Investment Officer. The COO is William Rahm, who oversees the firm's operations and infrastructure.
Centerbridge Partners has a reputation for being a highly disciplined and opportunistic investor, with a focus on identifying undervalued assets and unlocking value through operational improvements. The firm has a track record of successfully investing in a range of industries, including healthcare, energy, and financial services.
One notable investment made by Centerbridge Partners was its acquisition of Syncora Holdings, a financial guarantee insurance company, in 2013. The firm was able to turn around the struggling company by implementing operational improvements and strategic initiatives, ultimately leading to a successful exit.
Overall, Centerbridge Partners is a well-respected investment management firm with a strong leadership team and a proven track record of success.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GENCO SHIPPING & TRADING LTD | 26 | Q4 2022 | 18.0% |
| AMERICAN RENAL ASSOCS HLDGS | 19 | Q4 2020 | 34.8% |
| EXTENDED STAY AMER INC | 18 | Q4 2020 | 64.1% |
| AMBAC FINL GROUP INC | 17 | Q1 2018 | 4.8% |
| QUAD / GRAPHICS INC | 16 | Q4 2017 | 6.1% |
| IRSA INVERSIONES Y REP S A | 16 | Q3 2019 | 1.4% |
| ALLY FINL INC | 15 | Q4 2017 | 12.4% |
| WMIH CORP | 13 | Q3 2018 | 2.5% |
| CRESUD S A C I F Y A | 13 | Q4 2016 | 0.8% |
| ATLANTICA YIELD PLC | 12 | Q1 2019 | 9.0% |
View Centerbridge Partners's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| KV PHARMACEUTICAL CO /DE/ | March 03, 2011 | ? | ? |
View Centerbridge Partners's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP/A | 2024-03-04 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 40-APP | 2023-10-16 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Centerbridge Partners's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.